Psychometric properties of the Iranian version of colorectal cancer specific quality of life questionnaire (EORTC QLQ-CR29)
AbstractBackground: The authors selected European Organization for Research and Treatment (EORTC) C30 and EORTC QLQ CR29 to specify bowel, bladder, and sexual dysfunction of Iranian colorectal cancer patients.Methods: A sample of 100 patients with colorectal cancer attending Iran Cancer Institute from March 2012 to March 2013 at first-line chemotherapy in the adjuvant or palliative settings participated in the study. Patients responded to the study questionnaires at the beginning and after 3-4 cycles of chemotherapies. Responses to the core questionnaire (QLQ-C30) and the QLQ-CR29 were linearly converted into 0-100 scores, using the EORTC guidelines. Correlations between the QLQ-C30 and QLQ-CR29 were examined, using Pearson’s product moment correlation in order to assess construct validity. Known groups’ comparon examined the ability of EORCT-CR29 to dtinguh between subgroups of patients with and without a stoma. Sensitivity to changes over time was examined by the response to chemotherapy in palliative or neoadjuvant settings. Internal constency was measured using Cronbach’s alpha coefficient with estimates of a magnitude of 0.7.Results: The mean age of patients was 53.6. Based on clinical and pathologic staging, 60% of the patients had presented while their cancer was in stage IV with dtant metastas at the time of referring to the clinic. Thirty-three percent of patients, almost all from rectal tumor group, had a permanent ostomy. In general, the correlation between the EORTC QLQ-C30 and QLQ-CR29 was in the expected directions, demonstrating that functional scales of both questionnaires had a positive correlation with each other while negative correlation was observed between functional and symptom subscales. In addition, the QLQ-CR29 differed considerably between patients with and without a stoma.The QLQ-CR29 results showed improved functioning scores after treatment and at the same time symptoms decreased. The Cronbach’s alpha for the scales ranged from 0.48-0.77.Conclusion: In general, the Iranian version of the EORTC QLQ-CR29 worked well and now could be used in outcome studies in colorectal cancer.
Blazeby JM, Avery K, Sprangers M, Pikhart H, Fayers P, Donovan J. Health-related quality of life measurement in randomized clinical trials in surgical oncology. Journal of Clinical Oncology. 2006 Jul 1;24(19):3178-86.
Gujral S, Conroy T, Flesner C, Sezer O, King PM, Avery KN, Sylvester P, Koller M, Sprangers MA, Blazeby JM. Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire. European journal of cancer. 2007 Jul 1;43(10):1564-73.
Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, Hölzel D. Quality of life in rectal cancer patients: a four-year prospective study. Annals of surgery. 2003 Aug;238(2):203.
Neuman HB, Schrag D, Cabral C, Weer MR, Paty PB, Guillem JG, Minsky BD, Wong WD, Temple LK. Can differences in bowel function after surgery for rectal cancer be identified by the European Organization for Research and Treatment of Cancer quality of life instrument?. Annals of surgical oncology. 2007 May 1;14(5):1727-34.
Sailer M, Fuchs KH, Fein M, Thiede A. Randomized clinical trial comparing quality of life after straight and pouch coloanal reconstruction. Brith journal of surgery. 2002 Sep 1;89(9):1108-17.
Guren MG, Eriksen MT, Wiig JN, Carlsen E, Nesbakken A, Sigurdsson HK, Wibe A, Tveit KM. Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. European Journal of Surgical Oncology. 2005 Sep 1;31(7):735-42.
Arraras JI, Suárez J, Arias de la Vega F, Vera R, Asín G, Arrazubi V, et al. The EORTC quality of life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanh patients. Clinical and Translational Oncology. [journal article]. 2011 January 01;13(1):50-6.
Nelson R. Survival rates increasing in metastatic colorectal cancer. Journal of Clinical Oncology. 2009;27.
EORTC Quality of Life Department. Available from: http://www.groups.eortc.be/qol. EORTC.
Pachler J, Wille-Jorgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev. 2005 Jan 1;2.
Clinical and psychometric validation of the EORTC QLQ-CR29questionnaire module to assess health-related quality of life in patients with colorectal cancer. Euro J of Cancer.
Lin JB, Zhang L, Wu DW, Xi ZH, Wang XJ, Lin YS, Fujiwara W, Tian JR, Wang M, Peng P, Guo A. Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer. World journal of gastroenterology. 2017 Mar 14;23(10):1891.